Discovery Life Sciences partners with Olink to support proteomics research and accelerate precision medicine programs
UPPSALA, Sweden,, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it has entered into an agreement with Discovery Life Sciences™ (Discovery) to establish the largest commercial platform of the Olink® technology in the Americas outside of Olink, and provide the market with a global "one-stop shop" to support the discovery and validation of proteomics at scale and with high specificity across all major biological pathways and sample matrices.
“Protein biomarker discovery can help bridge the gap between genomes and phenotypes, enabling improved understanding of real-time human biology and a stronger grasp of the transition from health to disease. With its high specificity, precision, and sensitivity, at scale, Olink’s PEA technology addresses limitations that historically impeded advanced proteomics,” said Jon Heimer, CEO of Olink. “We are excited to support Discovery Life Sciences on their mission to embrace the promise of proteomics through our innovative and unique technology and help leverage its potential for their customers worldwide.”
Olink’s agreement with Discovery, which includes Olink® Explore and the Signature Q100 instrument, represents the latest addition to the rapidly growing community of service providers. This group is collectively embracing Olink’s proteomics platform, from high-plex to low-plex and across major geographies around the world, further growing the proteomics market and increasing Olink’s reach with new customers.
“Olink’s PEA technology is a unique antibody-based proteomic technology with features that solve the dynamic range issue that has hindered proteomics: allowing the detection and quantitation of low and high abundant proteins,” said Michael Pisano, Ph.D., Executive Vice President of Proteomics at Discovery. “Discovery is excited to add this significant installation of the Olink® technology to our extensive menu of proteomic services and optimized workflows that accelerate precision medicine programs through every stage of development, at any scale.”
Discovery will offer Olink® PEA technology to complement their genomic, cell biology, and tissue biomarker services, providing multi-omic analyses that inform and accelerate decision-making throughout drug and diagnostic development.
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
Corporate Communications Manager
Mobile: +46 768 775 275
Olink Holding AB (publ) (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major pharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.
About Discovery Life Sciences
Discovery Life Sciences is the company of Biospecimen and Biomarker Specialists, combining the world’s largest commercial biospecimen inventory and procurement network with preeminent multi-omic biomarker service laboratories, including genomic, tissue biomarker, proteomic, and cell-based services to accelerate new therapies supported by biomarker and companion diagnostic programs for cancer, infectious disease, and other rare and complex conditions. Through AllCells, our cell and gene therapy division, we offer one of the largest recallable donor pools, Research Use Only (RUO) and clinical-grade (GMP) fresh and cryopreserved human cellular materials to support cell and gene therapy programs at any scale from start to finish. Driven by leading scientific expertise and innovative use of current technologies, the Discovery team engages and consults with customers to rapidly overcome obstacles and obtain results to make critical research and development decisions at market-leading speed. We are Science at your Service™! For more information, visit dls.com.
This release may contain forward-looking statements within the meaning of applicable securities laws, including the U.S. Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding Olink’s strategy, business plans and focus. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management’s current expectations and beliefs as of the date hereof and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those related to Olink’s business, operations, supply chain, strategy, goals and anticipated timelines, including for the delivery of Olink Explore 3072 and the expansion of the Explore platform, competition, and other risks identified in the section entitled “Risk Factors” in Olink’s Registration Statement on Form F-1, as amended (File No. 333-253818) filed with the U.S. Securities and Exchange Commission (SEC) and in the other filings, reports, and documents Olink files with the SEC from time to time. Olink expressly disclaims any obligation to update any forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, unless required by law or regulation.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Lytho Appoints Geert Bruinink to Lead Operations in Europe27.9.2022 10:00:00 CEST | Press release
Seasoned Executive Brings a Mix of General Management and Sales Leadership as the Company Expands Reach in Europe for its Creative Workflow and Digital Asset Management (DAM) Software AMSTERDAM, the Netherlands and RALEIGH, N.C., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Lytho, a creative operations platform providing creative workflow and digital asset management (DAM) tools to brand and creative teams, today announced it has hired Geert Bruinink as its Country Manager based in The Netherlands. He will report to Lytho CEO Douglas Thede and have overall responsibility for the company’s European sales and operations. “Geert brings a proven track record of general management and sales leadership skills to Lytho as we extend our presence in Europe,” said Thede. “We’ve seen strong demand for our software because in-house creative teams have grown, and our tools reduce the natural complexity that comes with that growth. We’re thrilled to welcome Geert as a Lythonian and look forward to his contrib
Conagen unveils commercial production of high-purity non-GMO salidroside27.9.2022 10:00:00 CEST | Press release
Ideal for adaptogen supplement solutions and natural preservatives in food and beverages. Bedford, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Conagen announced the commercialization of its 99% high-purity salidroside made by bioconversion technology, an active ingredient from the herbal plant Rhodiola rosea (golden root). Its strong antioxidant properties as an adaptogen are associated with reducing inflammation, protecting against oxidative stress in cells, and providing relief from depression, fatigue, and stress. Salidroside has also been used to alleviate high altitude sickness. Unlike other salidroside products currently on the market, Conagen’s salidroside is non-GMO. Conagen leveraged its industry-leading bioconversion technology to produce clean, sustainable salidroside, identical to the compound naturally found in the Rhodiola rosea plant --- the same technology used to produce non-GMO Rebaudioside M, other steviol glycosides, and bitter blockers for sugar reduction solutions w
SATO announces new Sustainability Programme spearheaded by sustainable housing and wellbeing in communities27.9.2022 10:00:00 CEST | Press release
SATO Corporation Press release 27 September 2022 at 11:00 am SATO, one of Finland’s largest rental housing providers, has released its new Sustainability Programme for 2023–2026.The programme is themed on sustainable housing, wellbeing in communities and sustainable profitability. SATO is one of Finland’s biggest rental housing providers, holding around 25,000 rental homes occupied by some 50,000 residents. SATO’s new Sustainability Programme, the second of its kind, builds on three pillars: environmental, social as well as economic sustainability and sustainable governance. “Last year, we made sustainability one of the three cornerstones of our strategy. Sustainability is a key component in our long-term value generation for our various stakeholders. It is about concrete actions that can be seen in everything we do. We aim to be a forerunner in sustainable rental housing,” says Susanna Kari Gonzaléz, Sustainability Manager at SATO. SATO’s sustainable operating principles lay the found
Duck Creek Technologies Focuses on Enhancing Distribution Channels and Speed to Market for Insurers with UK / EMEA Expansion of Duck Creek Producer27.9.2022 09:30:00 CEST | Press release
London, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Duck Creek Technologies (NASDAQ: DCT), the intelligent solutions provider defining the future of property and casualty (P&C) insurance, is pleased to announce today the international expansion of Duck Creek Producer, a cutting-edge platform for enhancing the relationships between insurers and brokers and accelerating speed-to-market for distributing new products. Duck Creek Producer was launched in the US in 2020 and has been gaining strong traction, including a recent implementation for Arbella Insurance Group, a North American underwriter of personal and commercial lines insurance products. Duck Creek Producer’s functionality has now been extended globally, with the UK / EMEA markets a key growth area. Duck Creek Producer enables insurers to maximise operational efficiency by delivering genuinely valuable and satisfying portal experiences that result in more productive and loyal agents, brokers and other intermediaries. Incorporating extensi
Hexagon Ragasco, the world’s leading manufacturer of composite LPG cylinders, awarded new Environmental Product Declaration27.9.2022 09:00:00 CEST | Press release
Hexagon Ragasco, a Hexagon company and world leading manufacturer of LPG composite cylinders – was awarded a new Environmental Product Declaration (EPD) from EPD-Norway covering the entire lifetime of their cylinders from cradle to grave. Hexagon Ragasco’s cylinders are produced at the company’s fully automated manufacturing plant in Raufoss, Norway. During the past 22 years, Hexagon Ragasco has sold over 20 million cylinders to close to 100 countries. Value of an Environmental Product Declaration (EPD) An EPD discloses a product’s life cycle environmental impact and helps users to identify sustainable products. Both the underlying Life-Cycle Assessment (LCA) and the EPD are based upon international standards. Furthermore, it contains quantified information that enables comparison between products from the same product category and declares its environmental footprint towards predetermined environmental factors; one being the product’s carbon footprint. Hexagon Ragasco’s first EPD cove